Explain this page
Arphra AIPlain-English read on Chemed Corporation’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for CHE.
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.06% | -2.58% | +1.01% | +4.00% | -2.59% | -0.34% | -25.24% | -20.06% | -12.92% | +220.10% | +4509.84% |
Aftermarket
Live · FMPLast trade
$426.30
388 sh
Bid
$374.00
10 sh
Ask
$450.00
10 sh
Spread
$76.000
Sector & industry today
Live · FMPSectors
- Technology+0.21%
- Basic Materials+0.15%
- Financial Services-0.43%
- Industrials-0.48%
- Energy-0.58%
- Consumer Defensive-0.79%
- Consumer Cyclical-0.85%
- Real Estate-0.98%
- Healthcare-1.37%
- Communication Services-1.47%
- Utilities-2.07%
Top industries (issuer's industry highlighted)
- Medical - Care Facilities-1.16%
- Software - Infrastructure+6.80%
- Coal-6.27%
- Information Technology Services+6.00%
- Medical - Healthcare Information Services+5.23%
- Other Precious Metals+3.84%
- Broadcasting-3.48%
- Silver+2.89%
- Renewable Utilities-2.75%
- Software - Application+2.71%
- Travel Lodging-2.70%
- Internet Content & Information-2.61%
Fair value
Football field →Weighted blend
$431.44
+1.18% vs spot
Recommendation
Hold
4 of 4 methods
Method spread
2bull1bear
±5% threshold
Analyst PT consensus: $475.00 (+11.40%)
Total assets
$1.64B
Total debt
$154.76M
Cash & equiv
$74.52M
Operating CF
$388.27M
Free cash flow
$325.48M
Buybacks
-$431.5M
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Chemed Corporation to Present at the 2026 RBC Global Healthcare Conferenceglobenewswire.com·May 13, 2026
- Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcriptseekingalpha.com·May 12, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $657.51M | $66.3M | $4.85 |
| Q4 Dec 2025 | $639.34M | $76.75M | $5.48 |
| Q3 Sep 2025 | $624.9M | $64.24M | $4.46 |
| Q2 Jun 2025 | $618.8M | $52.49M | $3.57 |
| Q1 Mar 2025 | $646.94M | $71.76M | $4.86 |
| Q4 Dec 2024 | $639.99M | $90.32M | $6.02 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $2.53B | $338.25M | $265.24M | $18.42 | +10.48% |
| FY 2024 | $2.43B | $366.49M | $302M | $19.89 | +12.42% |
| FY 2023 | $2.26B | $340.57M | $272.51M | $17.93 | +12.03% |
| FY 2022 | $2.13B | $343.5M | $249.62M | $16.53 | +11.69% |
| FY 2021 | $2.14B | $343.04M | $268.55M | $16.85 | +12.55% |